Skip to main content
logo
Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
128.38
+0.20 (0.16%)
Jul 1, 2025, 3:00 PM - Market open

Blueprint Medicines Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product
535.84M 478.95M 405.86M 331.90M 257.66M 204.21M 163.24M 137.64M
Product Growth
107.96% 134.54% 148.63% 141.13% 104.14% 83.98% 61.69% 53.63%
Collaboration License and Other
- 29.87M - 30.89M 24.55M 45.17M 52.97M 60.47M
Collaboration License and Other Growth
- -33.87% - -48.91% -51.75% -31.08% -63.17% -57.08%

Revenue by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
468.15M 421.84M 361.35M 297.33M 230.18M 181.97M 144.52M 120.45M
United States Growth
103.38% 131.82% 150.04% 146.85% 107.70% 87.16% - -
Rest of World
67.69M 57.11M 44.51M 34.57M 27.48M 22.24M 18.72M 17.19M
Rest of World Growth
146.30% 156.85% 137.78% 101.06% 78.51% 61.52% - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.